DE3682874D1 - Pyranoindolizinderivate und verfahren zu ihrer herstellung. - Google Patents

Pyranoindolizinderivate und verfahren zu ihrer herstellung.

Info

Publication number
DE3682874D1
DE3682874D1 DE8686114231T DE3682874T DE3682874D1 DE 3682874 D1 DE3682874 D1 DE 3682874D1 DE 8686114231 T DE8686114231 T DE 8686114231T DE 3682874 T DE3682874 T DE 3682874T DE 3682874 D1 DE3682874 D1 DE 3682874D1
Authority
DE
Germany
Prior art keywords
pyranoindolicine
derivatives
production
pyranoindolicine derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE8686114231T
Other languages
English (en)
Inventor
C O Daiichi Seiyaku Res Tagawa
C O Daiichi Seiyaku R Terasawa
C O Daiichi Seiyaku Res Ejima
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Daiichi Pharmaceutical Co Ltd
Yakult Honsha Co Ltd
Original Assignee
Daiichi Pharmaceutical Co Ltd
Yakult Honsha Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Daiichi Pharmaceutical Co Ltd, Yakult Honsha Co Ltd filed Critical Daiichi Pharmaceutical Co Ltd
Application granted granted Critical
Publication of DE3682874D1 publication Critical patent/DE3682874D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/12—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains three hetero rings
    • C07D493/14—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE8686114231T 1985-10-21 1986-10-14 Pyranoindolizinderivate und verfahren zu ihrer herstellung. Expired - Lifetime DE3682874D1 (de)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
JP23336685 1985-10-21
JP29612785 1985-12-25
JP19482286 1986-08-20
JP19482186 1986-08-20

Publications (1)

Publication Number Publication Date
DE3682874D1 true DE3682874D1 (de) 1992-01-23

Family

ID=27475728

Family Applications (1)

Application Number Title Priority Date Filing Date
DE8686114231T Expired - Lifetime DE3682874D1 (de) 1985-10-21 1986-10-14 Pyranoindolizinderivate und verfahren zu ihrer herstellung.

Country Status (4)

Country Link
US (1) US4778891A (de)
EP (1) EP0220601B1 (de)
JP (1) JPH0737460B2 (de)
DE (1) DE3682874D1 (de)

Families Citing this family (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5364858A (en) * 1987-03-31 1994-11-15 Research Triangle Institute Camptothecin analogs as potent inhibitors of topoisomerase I
US4981968A (en) * 1987-03-31 1991-01-01 Research Triangle Institute Synthesis of camptothecin and analogs thereof
US5053512A (en) * 1987-04-14 1991-10-01 Research Triangle Institute Total synthesis of 20(S) and 20(R)-camptothecin and compthothecin derivatives
US5106742A (en) * 1987-03-31 1992-04-21 Wall Monroe E Camptothecin analogs as potent inhibitors of topoisomerase I
US4894456A (en) * 1987-03-31 1990-01-16 Research Triangle Institute Synthesis of camptothecin and analogs thereof
US5122526A (en) * 1987-03-31 1992-06-16 Research Triangle Institute Camptothecin and analogs thereof and pharmaceutical compositions and method using them
US5122606A (en) * 1987-04-14 1992-06-16 Research Triangle Institute 10,11-methylenedioxy camptothecins
US5340817A (en) * 1987-04-14 1994-08-23 Research Triangle Institute Method of treating tumors with anti-tumor effective camptothecin compounds
US5180722A (en) * 1987-04-14 1993-01-19 Research Triangle Institute 10,11-methylenedioxy-20(RS)-camptothecin and 10,11-methylenedioxy-20(S)-camptothecin analogs
US5049668A (en) * 1989-09-15 1991-09-17 Research Triangle Institute 10,11-methylenedioxy-20(RS)-camptothecin analogs
US4939255A (en) * 1987-06-24 1990-07-03 Daiichi Pharmaceutical Co., Ltd. Hexa-cyclic camptothecin derivatives
JPH0615547B2 (ja) * 1988-01-20 1994-03-02 株式会社ヤクルト本社 新規なカンプトテシン誘導体
US5225404A (en) * 1989-11-06 1993-07-06 New York University Methods of treating colon tumors with tumor-inhibiting camptothecin compounds
US5552154A (en) * 1989-11-06 1996-09-03 The Stehlin Foundation For Cancer Research Method for treating cancer with water-insoluble s-camptothecin of the closed lactone ring form and derivatives thereof
HU213136B (en) * 1990-08-14 1997-02-28 Kyorin Seiyaku Kk Process for producing fluoroethyl camptothecin derivatives and pharmaceutical compositions containing them
US5559235A (en) * 1991-10-29 1996-09-24 Glaxo Wellcome Inc. Water soluble camptothecin derivatives
US6080751A (en) * 1992-01-14 2000-06-27 The Stehlin Foundation For Cancer Research Method for treating pancreatic cancer in humans with water-insoluble S-camptothecin of the closed lactone ring form and derivatives thereof
JPH08502044A (ja) * 1992-08-21 1996-03-05 デイナ・フアーバー・キヤンサー・インステイテユート ヒトウイルス感染の治療
US5342947A (en) * 1992-10-09 1994-08-30 Glaxo Inc. Preparation of water soluble camptothecin derivatives
US5447936A (en) * 1993-12-22 1995-09-05 Bionumerik Pharmaceuticals, Inc. Lactone stable formulation of 10-hydroxy 7-ethyl camptothecin and methods for uses thereof
US5468754A (en) * 1994-04-19 1995-11-21 Bionumerik Pharmaceuticals, Inc. 11,7 substituted camptothecin derivatives and formulations of 11,7 substituted camptothecin derivatives and methods for uses thereof
US5604233A (en) * 1994-04-28 1997-02-18 Bionumerik Pharmaceuticals, Inc. Lactone stable formulation of 7-ethyl camptothecin and methods for uses thereof
US5597829A (en) * 1994-05-09 1997-01-28 Bionumerik Pharmaceuticals, Inc. Lactone stable formulation of camptothecin and methods for uses thereof
US5491237A (en) * 1994-05-03 1996-02-13 Glaxo Wellcome Inc. Intermediates in pharmaceutical camptothecin preparation
US5646159A (en) * 1994-07-20 1997-07-08 Research Triangle Institute Water-soluble esters of camptothecin compounds
US5614529A (en) * 1994-09-22 1997-03-25 Research Triangle Institute Inhibition of plasmodia parasites by camptothecin compounds
TW438775B (en) * 1995-04-07 2001-06-07 Pharmacia & Upjohn Co Llc Novel intermediates and process for the manufacture of camptothecin derivatives (CPT-11) and related compounds
US5726181A (en) * 1995-06-05 1998-03-10 Bionumerik Pharmaceuticals, Inc. Formulations and compositions of poorly water soluble camptothecin derivatives
SG50747A1 (en) * 1995-08-02 1998-07-20 Tanabe Seiyaku Co Comptothecin derivatives
AU7732996A (en) * 1995-11-22 1997-06-11 Research Triangle Institute Camptothecin compounds with combined topoisomerase i inhibition and dna alkylation properties
CA2192725C (en) * 1995-12-28 2004-04-20 Kenji Tsujihara Camptothecin derivatives
SG104284A1 (en) 1996-10-30 2004-06-21 Tanabe Seiyaku Co S type 2-substituted hydroxy-2-indolidinylbutyric ester compounds and process for preparation thereof
US6559309B2 (en) 1996-11-01 2003-05-06 Osi Pharmaceuticals, Inc. Preparation of a camptothecin derivative by intramolecular cyclisation
US6332193B1 (en) * 1999-01-18 2001-12-18 Sensar, Inc. Method and apparatus for securely transmitting and authenticating biometric data over a network
CA2395567A1 (en) * 2000-01-12 2001-07-19 Light Sciences Corporation Novel treatment for eye disease
US7595400B2 (en) 2003-02-21 2009-09-29 Chugai Seiyaku Kabushiki Kaisha Process for the preparation of hexacyclic compounds
NZ550665A (en) 2004-04-09 2010-05-28 Chugai Pharmaceutical Co Ltd Novel water-soluble prodrugs of camptothecin derivatives
CN100390177C (zh) * 2004-11-25 2008-05-28 复旦大学 6-氰基-7-甲基-1,1-(2,2-二甲基-1,3-亚丙二氧基)-5-氧-1,2,3,5-四氢吲哚哩啶(i)的制备方法
TW200744603A (en) 2005-08-22 2007-12-16 Chugai Pharmaceutical Co Ltd Novel anticancer concomitant drug
CN103087072B (zh) * 2013-02-05 2014-02-26 复旦大学 一种（+）-三环羟内酯制备方法
CN104341429B (zh) * 2013-07-29 2016-08-10 北大方正集团有限公司 (s)-喜树碱中间体的制备方法及(s)-喜树碱的制备方法
CN104650107A (zh) * 2015-02-12 2015-05-27 复旦大学 一种4-乙基-6,6-双取代烷氧基-7,8-二氢-1H-吡喃[3,4-f]中氮茚-3,10(4H) -二酮(Ⅰ)的制备方法
CN108570057A (zh) * 2017-03-13 2018-09-25 烟台药物研究所 一种合成7-乙基-10-羟基喜树碱的方法
US11318212B2 (en) 2017-08-31 2022-05-03 Daiichi Sankyo Company, Limited Method for producing antibody-drug conjugate

Also Published As

Publication number Publication date
JPS63152382A (ja) 1988-06-24
EP0220601A1 (de) 1987-05-06
US4778891A (en) 1988-10-18
EP0220601B1 (de) 1991-12-11
JPH0737460B2 (ja) 1995-04-26

Similar Documents

Publication Publication Date Title
DE3682874D1 (de) Pyranoindolizinderivate und verfahren zu ihrer herstellung.
DE3577552D1 (de) Vitamin d-derivate und verfahren zu deren herstellung.
DE3688093D1 (de) Durchsichtiger gegenstand und verfahren zu seiner herstellung.
DE3782994T2 (de) Erythromycin-a-derivate und verfahren zu ihrer herstellung.
DE3482823D1 (de) Dihydropyridin-derivate und verfahren zu ihrer herstellung.
DE3675741D1 (de) Vernetzte copolyamidimide und verfahren zu deren herstellung.
DE3680859D1 (de) Chinolinderivate und verfahren zu deren herstellung.
DE3686597T2 (de) Uricase und verfahren zu deren herstellung.
DE3878475D1 (de) Organopolysiloxanemulsion und verfahren zu ihrer herstellung.
DE3482258D1 (de) 2,2-difluorpropionsaeurederivate und verfahren zu ihrer herstellung.
DE3582466D1 (de) Aminoalkohol-derivate und verfahren zu ihrer herstellung.
DE3673515D1 (de) Gonatrien-derivate und verfahren zu ihrer herstellung.
DE3685013D1 (de) Amino-trifluormethylpyridinverbindung und verfahren zu ihrer herstellung.
DE3785694D1 (de) Thiophenderivate und verfahren zu ihrer herstellung.
DE3765181D1 (de) Isocarbacycline und verfahren zu ihrer herstellung.
DE3778517D1 (de) 7-brom-beta-carbolin-derivate und verfahren zu ihrer herstellung.
DE3677259D1 (de) Chinazolinonverbindungen und verfahren zu ihrer herstellung.
DE3578884D1 (de) Chinoloncarbonsaeure derivate und verfahren zu ihrer herstellung.
PT81713A (de) Oeladjuvierte vaccine und verfahren zu ihrer herstellung
DE3672931D1 (de) Chinoloncarbonsaeurederivate und verfahren zu ihrer herstellung.
DE3878578D1 (de) Benzimidazol-derivate und verfahren zu ihrer herstellung.
DE3674733D1 (de) Vernetzbare polycyclische polycarbonatoligomere und verfahren zu ihrer herstellung.
AT399879B (de) Dihydro-pyrimido-thiazin-derivate und verfahren zu ihrer herstellung
DE3765239D1 (de) Acetylketendialkylacetale und verfahren zu ihrer herstellung.
DE3860496D1 (de) Cyanoguanidinderivate und verfahren zu deren herstellung.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition